EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
The CEO of Biogen Idec told investors Tuesday that he expects to see more cases of a rare, fatal brain disorder in patients taking the drug Tysabri, Reuters reported Tuesday.
But James Mullen, the executive, thinks the problems are unlikely to create more regulatory problems for Tysabri, a multiple sclerosis drug pulled temporarily from the market in 2005 thanks to the brain disease.
(hope I am not pissing off Ty users by posting negative articles. I figure knowledge is power...)
Joined: May 26, 2004 Posts: 1356 Location: London, ON, Canada
Posted: Wed Mar 19, 2008 7:30 am Post subject: Re: Biogen CEO predicts more brain disorders in Tysabri pati
Quote:
(hope I am not pissing off Ty users by posting negative articles. I figure knowledge is power...)
Rainer....what's negative about your posting? It's something that the CEO of Biogen stated and is likely scientific fact. It may not be what some Tysabri users like to hear but it certainly is not "negative."
I'm afraid there is going to be more problems with this drug as time goes by but we'll just have to wait and see as more data becomes available.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
Forum FAQ
Search
Usergroups
Profile
Log in to check your private messages
Log in
